Sproutly receives research license from Heath Canada

Twitter icon
logo

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), is pleased to announce that the company's wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR"), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.

"We are pleased to receive this license since we can now evaluate our proprietary extracts and the unique 2.0 product formulations before moving them forward to manufacturing and sale to Canadian consumers." said Arup Sen, CEO & Director.

"We believe it is important to know the sensory characters of the products we market and this license will allow us to further improve upon our beverage and edible product candidates", he added.

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Article category: 
Regional Marijuana News: